← SEC 公告列表 | NBRGU SEC 公告 | Newbridge Acquisition Ltd(NBRGU)

重大事件 即時報告 8-K 2026-08-03

Newbridge Acquisition與Startech簽業務合併協議 涉發1億股普通股

於 SEC 網站開啟原文

AI 繁中摘要

Newbridge Acquisition Limited(納斯達克:NBRGU)於2026年8月3日宣布,已與Startech Group Inc.簽訂業務合併協議。Startech為一家總部位於美國的生命科學科技公司,專注開發功能水及AI驅動的健康科技產品,以延長人類壽命為目標。是次交易已獲雙方董事會一致批准。 根據協議,Newbridge將由英屬維爾京群島遷冊至美國特拉華州,成為特拉華州公司,其全資附屬合併子公司將與Startech合併。完成後,Startech將成為合併公司的全資附屬公司,Startech股東及管理層將獲發1億股合併公司普通股作為對價,部分股份設有六個月禁售期。合併後公司將繼續在納斯達克上市,並會更換新的股票代號。 Startech業務分兩大板塊:AQP Water專注功能水產品,預期透過按瓶技術及結算服務費產生收入;StarOS則為面向AI時代的代理操作系統,旨在透過AI軟件及平台服務變現。兩者結合消費產品收入與可擴展的AI平台收入模式。 交易完成須待多項條件達成,包括取得監管機構批准、雙方股東表決通過,以及向美國證交會(SEC)提交的S-4註冊聲明(含委託投票書/招股書)生效,並獲納斯達克批准合併公司上市申請。有關文件將在SEC網站公開。 本次屬SPAC(空白支票公司)併購交易。對投資者而言,此類交易存在不確定性,包括審批時間、合併後公司執行能力,以及Startech的AI及功能水業務能否如期產生收入。合併完成前,NBRGU股價料會受交易進展消息主導;完成後則須重新審視合併公司基本因素及新業務風險。相關風險因素將詳列於稍後提交的S-4文件內。
展開英文正文
EX-99.1
5
ea030022801ex99-1.htm
JOINT PRESS RELEASE, DATED AUGUST 3, 2026

 

Exhibit 99.1

 

Newbridge Acquisition
Limited
Announces entering into the Business Combination Agreement with
Startech Group Inc.

 

DELAWARE, U.S.,
August 3, 2026 – Newbridge Acquisition Limited (Nasdaq: NBRGU) (the “Company”) today announced the execution of
the business combination agreement (the “Business Combination Agreement”) with Startech Group Inc., an emerging life sciences
technology company focused on developing products such as functional water and AI-powered healthcare technologies to enhance human longevity
(“Startech”).

 

Pursuant to the Business
Combination Agreement, at least one business day prior to the closing date of the business combination, the Company will continue out
of the British Virgin Islands and into the State of Delaware so as to re-domicile as and become a Delaware corporation by way of continuation
(the Company after such domestication, the “Domesticated Company”), Newbridge Merger Sub, Inc., a Delaware corporation (“Merger
Sub”) and wholly owned subsidiary of the Company, will be merged with and into Startech, resulting in Startech being a wholly owned
subsidiary of the Domesticated Company (the “Business Combination” and the transactions in connection with the Business Combination
collectively, the “Transaction”). Upon the closing of the Transaction, the parties plan to remain Nasdaq-listed under a new
ticker symbol.

 

Startech Overview

 

Startech is a U.S.-based
Al technology company with fintech-enablement capabilities, operating through two complementary business segments: aquaporin functional
water (“AQP Water”) and the StarOS platform, an agent operating system designed for the Al era (“StarOS”). The
AQP Water segment is focused on the Company’s functional-water business and is expected to generate contractual per-bottle technology
and settlement service revenue linked to product sales and digital product management. The StarOS segment represents the Company’s
Al platform business and is intended to generate revenue from AI-enabled software and platform services. Together, these business segments
are intended to combine consumer-product-related revenue opportunities with potentially scalable AI software and platform-based revenue
opportunities.

 

Key Transaction
Terms

 

Under the terms of
the Business Combination Agreement, Merger Sub, the Company’s wholly owned subsidiary, will be merged with and into Startech, resulting
in Startech being a wholly owned subsidiary of the Domesticated Company. At the effective time of the Transaction, Startech’s stockholders
and management will receive 100,000,000 common stock of the Domesticated Company. The shares held by certain Startech’s stockholders
will be subject to lock-up agreements for a period of six months following the closing of the Transaction, subject to certain exceptions.

 

The Transaction, which
has been unanimously approved by the boards of directors of both the Company and Startech, is subject to regulatory approvals, the approvals
by the shareholders of the Company and Startech, respectively, and the satisfaction of certain other customary closing conditions, including,
among others, a registration statement, of which the proxy statement/prospectus forms a part, being declared effective by the U.S. Securities
and Exchange Commission (the “SEC”), and the approval by Nasdaq of the listing application of the combined company.

 

The description of
the Business Combination contained herein is only a summary and is qualified in its entirety by reference to the Business Combination
Agreement. A more detailed description of the Transaction and a copy of the Business Combination Agreement will be included in a Current
Report on Form 8-K to be filed by the Company with the SEC and will be available on the SEC’s website at www.sec.gov.

 

Advisors

 

Loeb & Loeb LLP
and Forbes Hare serve as legal counsel to the Company. Torres & Zheng Law, P.C. serves as legal counsel to Startech.

 

  

  

 

 

About Newbridge
Acquisition Limited

 

Newbridge Acquisition
Limited is a blank check company incorporated as a British Virgin Islands business company for the purpose of entering into a merger,
share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses
or entities. The Company’s efforts to identify a prospective target business will not be limited to a particular industry or geographic
region.

 

About Startech Group
Inc.

 

Startech Group Inc.
is a Delaware corporation focused on fintech and AI technology infrastructure. Startech’s initial business initiatives include the
development of functional water products and AI-powered healthcare technologies designed to improve human health and longevity.

 

Participants in
the Solicitation

 

Startech, the Company,
and their respective directors, executive officers and employees and other persons may be deemed to be participants in the solicitation
of proxies from the holders of the Company ordinary shares in respect of the proposed Transaction. Information about the Company’s
directors and executive officers and their ownership of the Company’s ordinary shares is currently set forth in the Company’s
prospectus related to its initial public offering dated January 29, 2026, as modified or supplemented by any Form 10-K, Form 3 or Form
4 filed with the SEC since the date of such filing. Other information regarding the interests of the participants in the proxy solicitation
will be included in a registration statement on Form S-4 (as may be amended from time to time) that will include a proxy statement and
a registration statement/preliminary prospectus (the “Registration Statement”) pertaining to the proposed Transaction when
it becomes available. These documents can be obtained free of charge from the sources indicated below.

 

No Offer or Solicitation

 

This press release
is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Transaction
and does not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company or a solicitation of any
vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except
by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended.

 

Important Information
about the Proposed Business Combination and Where to Find It

 

In connection with
the Transaction, the Company will file relevant materials with the SEC, including the Registration Statement. Promptly after the Registration
Statement is declared effective, the proxy statement/prospectus will be sent to all shareholders entitled to vote at the special meeting
relating to the Transaction. Before making any voting decision, securities holders of the Company are urged to read the proxy statement/prospectus
and all other relevant documents filed or that will be filed with the SEC in connection with the Transaction as they become available
because they will contain important information about the Transaction and the parties to the Transaction.

 

Shareholders will also
be able to obtain copies of the preliminary proxy statement/prospectus, the definitive proxy statement/prospectus, and other documents
filed or that will be filed with the SEC through the website maintained by the SEC at www.sec.gov, or by directing a request to the contacts
mentioned below.

 

Yongsheng Liu

[email protected]

Newbridge Acquisition Limited

Unit B 17/F, Success Commercial Building,

245-25, Hennessy Road, Wanchai, Hong Kong
Telephone: +44 207 297 3592

 

Jack Yeung

[email protected]

Startech Group Inc.

7700 Windrose

Plano, Texas 75024

 

 2

  

 

 

Forward-Looking
Statements

 

This press release
contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities
Litigation Reform Act of 1995. The Company’s and Startech’s actual results may differ from their expectations, estimates and
projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,”
“estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,”
“plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,”
“potential,” “might” and “continues,” and similar expressions are intended to identify such forward-looking
statements. These forward-looking statements include, without limitation, the Company’s and Startech’s expectations with respect
to future performance and anticipated financial impacts of the Business Combination, the satisfaction of the closing conditions to the
Business Combination and the timing of the completion of the Business Combination. These forward-looking statements involve significant
risks and uncertainties that could cause actual results to differ materially from expected results. Most of these factors are outside
the control of the Company or Startech and are difficult to predict. Factors that may cause such differences include, but are not limited
to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the Business Combination
Agreement relating to the proposed Business Combination; (2) the outcome of any legal proceedings that may be instituted against the Company
or Startech following the announcement of the Business Combination Agreement and the transactions contemplated therein; (3) the inability
to complete the Business Combination, including due to failure to obtain approval of the shareholders of the Company or other conditions
to closing in the Business Combination Agreement; (4) delays in obtaining or the inability to obtain necessary regulatory approvals required
to complete the transactions contemplated by the Business Combination Agreement; (5) the occurrence of any event, change or other circumstance
that could give rise to the termination of the Business Combination Agreement or could otherwise cause the transaction to fail to close;
(6) the inability to obtain or maintain the listing of the post-acquisition company’s ordinary shares on Nasdaq following the Business
Combination; (7) the risk that the Business Combination disrupts current plans and operations as a result of the announcement and consummation
of the Business Combination; (8) the ability to recognize the anticipated benefits of the Business Combination, which may be affected
by, among other things, competition, the ability of the combined company to grow and manage growth profitably and retain its key employees;
(9) costs related to the Business Combination; (10) changes in applicable laws or regulations; (11) the possibility that Startech or the
combined company may be adversely affected by other economic, business, and/or competitive factors; and (12) other risks and uncertainties
to be identified in the Registration Statement filed by the Company (when available) relating to the Business Combination, including those
under “Risk Factors” therein, and in other filings with the SEC made by the Company and Startech. The Company and Startech
caution that the foregoing list of factors is not exclusive. The Company and Startech caution readers not to place undue reliance upon
any forward-looking statements, which speak only as of the date made. Neither the Company nor Startech undertakes or accepts any obligation
or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations
or any change in events, conditions or circumstances on which any such statement is based, subject to applicable law. The information
contained in any website referenced herein is not, and shall not be deemed to be, part of or incorporated into this press release.

 

 

 3